Traumatic amputation of part of head

ST19_TRAUMAT_AMPUT_PART_HEAD

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — S08 Cause of death: ICD-10 — S08 2 out of 7 registries used, show all original rules.	60
4. Check minimum number of events None	60
5. Include endpoints None	60
6. Filter based on genotype QC (FinnGen only)	60

Control definitions (FinnGen only)

Control exclude: ST19_INJURI_HEAD

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: S0
Name in latin: Amputatio traumatica partis capitis

NAME	ST19_TRAUMAT_AMPUT_PART_HEAD
CONTROL_EXCLUDE	ST19_INJURI_HEAD
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	S08
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	S08
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Traumatic amputation of part of head based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	60	19	41
Unadjusted period prevalence (%)	0.01	0.01	0.02
Median age at first event (years)	48.55	41.95	51.61

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019309) Folate [Moles/volume] in Red Blood Cells

3.43

3.99

1.7

2.0

1163.0

1083.0

nmol/l

0.14

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

140

2.88

3.84

3.6

4.1

24.8

32.1

ng/l

0.46

(3023368) Bacteria identified in Blood by Culture

111

2.94

3.78

3.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2.94

3.55

3.7

4.0

27.3

471.1

ng/l

0.76

(3032080) INR in Blood by Coagulation assay

161

2.55

3.10

7.3

9.2

1.1

1.3

inr

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

147

2.52

2.99

1.8

2.0

90.7

90.3

pmol/l

0.01

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.69

1.9

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

3.88

2.60

2.0

1.3

—

(3016879) Cocaine [Presence] in Urine

3.88

2.60

2.0

1.3

—

(3027944) Amphetamines [Presence] in Urine

3.88

2.60

2.0

1.3

—

(3028300) Cannabinoids [Presence] in Urine

3.88

2.60

2.0

1.3

—

(3027008) Opiates [Presence] in Urine

3.88

2.60

2.0

1.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3.73

2.51

1.4

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

4.03

2.46

2.1

1.3

—

(3047181) Lactate [Moles/volume] in Blood

5.00

2.33

4.3

8.0

1.4

1.0

mmol/l

—

(3022313) Gas panel - Capillary blood

4.25

2.33

4.1

2.0

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

122

2.27

2.23

2.8

2.3

657.2

324.0

u/l

0.32

113

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

185

2.10

2.05

4.0

3.8

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3.26

2.02

10.5

8.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

260

2.10

2.01

6.4

5.0

7.7

6.7

mmol/l

0.40

247

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.84

1.89

1.2

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2.27

1.86

2.4

2.0

—

(3044640) Blood type and Crossmatch panel - Blood

108

2.11

1.77

2.3

2.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.43

1.75

1.7

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.38

1.68

1.8

—

(3019060) Gas panel - Arterial blood

2.80

1.57

3.1

5.6

—

(3003694) ABO and Rh group [Type] in Blood

123

1.94

1.49

1.3

1.7

—

(3026008) Bacteria identified in Urine by Culture

116

1.93

1.44

3.9

2.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

3.11

1.38

2.0

1.9

—

(1761868) Lipid panel - Serum or Plasma

164

0.47

1.35

2.2

2.6

—

(3000991) Gas panel - Venous blood

2.48

1.33

9.3

9.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2.34

1.27

1.3

1.4

—

(42870588) Differential panel, method unspecified - Blood

147

1.78

1.24

3.6

5.9

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

459

1.99

1.12

24.4

14.6

139.1

139.8

mmol/l

1.11

446

(3000850) Epithelial cells [#/volume] in Urine

1.84

1.10

2.3

2.0

2.6

5.0

e6/l

1.42

(3013650) Neutrophils [#/volume] in Blood by Automated count

246

1.64

1.06

6.8

11.0

4.3

4.2

e9/l

0.15

211

(3042936) Bacteria identified in Isolate by Culture

1.92

1.06

1.4

2.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2.38

1.05

1.8

2.0

2.4

0.1

e6/l

—

(3037467) Urinalysis macro (dipstick) panel - Urine

286

1.65

1.04

4.9

4.4

—

(3033658) Prothrombin time (PT) actual/Normal

102

1.78

1.04

4.4

3.3

85.7

96.7

1.24

102

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.13

1.04

1.1

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.94

1.02

1.2

1.7

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

146

1.67

1.01

3.7

3.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

462

1.94

0.99

24.5

14.6

4.0

mmol/l

0.11

449

(4010399)

2.01

0.97

1.4

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.83

0.93

1.3

1.7

—

(3027945) Reticulocytes/100 erythrocytes in Blood

2.04

0.93

1.5

2.4

1.9

1.7

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

479

1.91

0.90

22.4

15.2

76.3

81.0

umol/l

1.04

479

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.72

0.88

1.3

1.9

—

(3019225) pH of Specimen

1.97

0.84

3.7

2.8

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1.97

0.84

13.7

10.2

1.3

1.9

mmol/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.77

0.82

1.8

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.78

0.79

1.6

—

(3026782) Osmolality of Urine

1.72

0.79

2.3

2.1

621.1

555.4

mosm/kgh2o

0.50

(3012544) pH of Venous blood

1.90

0.75

4.1

3.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.65

0.73

1.8

1.4

—

(3025159) Blasts/100 leukocytes in Blood

2.00

0.72

4.8

4.2

—

0.9

—

(3021440) Promyelocytes/100 leukocytes in Blood

2.00

0.72

4.8

4.4

—

0.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

167

1.50

0.71

3.3

2.7

136.4

131.1

ug/l

0.05

154

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.86

0.68

1.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1.86

0.68

14.2

13.1

95.4

93.0

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1.86

0.68

4.8

3.9

—

0.6

—

(3017181) Myelocytes/100 leukocytes in Blood

1.73

0.63

4.8

4.1

—

0.7

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

0.00

0.61

0.0

1.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

0.00

0.59

0.0

1.5

—

352.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.00

0.59

0.0

2.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1.74

0.59

4.0

3.4

7.1

146.7

ug/l

—

(40761535) Cells panel - Urine sediment

1.74

0.59

2.3

3.5

—

(3002256) Pathology report gross observation

1.55

0.50

1.4

1.2

—

(3015736) pH of Urine

168

1.38

0.49

3.0

3.2

—

(3044889) 12 lead EKG panel

298

1.33

0.43

3.7

4.0

—

(4035726)

1.61

0.43

1.4

1.3

—

(3022621) pH of Urine by Test strip

1.61

0.43

2.2

1.9

—

(4094501)

0.00

0.42

0.0

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.40

0.0

1.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

214

1.29

0.36

4.3

4.5

0.0

estimate

—

(3000963) Hemoglobin [Mass/volume] in Blood

514

1.50

0.36

27.5

19.1

134.8

139.6

g/l

1.93

505

(3024731) MCV [Entitic volume]

514

1.50

0.36

27.2

19.0

91.3

90.7

0.52

505

(3035941) MCH [Entitic mass]

514

1.50

0.36

27.3

18.9

30.4

30.3

0.20

505

(3037522) Nuclear Ab [Titer] in Serum

1.34

0.34

1.0

1.5

—

351.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

491

1.44

0.32

12.1

9.6

24.7

28.9

u/l

1.04

473

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

326

1.26

0.32

4.4

2.9

53.6

45.5

u/l

0.41

309

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

408

1.29

0.32

5.4

5.3

40.5

40.1

mmol/mol

0.08

386

(3009542) Hematocrit [Volume Fraction] of Blood

419

1.30

0.31

22.8

14.4

39.7

41.5

0.62

324

(3035350) Ketones [Presence] in Urine by Test strip

218

1.25

0.30

3.3

3.4

0.0

estimate

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.33

0.29

1.6

2.5

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

420

1.29

0.29

16.5

11.7

86.4

85.4

ml/min/173m2

0.12

340

(36304419) Bacteria [Presence] in Urine

126

1.25

0.24

3.9

2.6

—

(36660697) Celiac disease serology panel - Serum

1.27

0.23

1.0

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.24

0.22

3.4

10.0

—

(3000492) Spirometry study

1.24

0.22

1.4

—

(40758558) Short blood count panel - Blood

108

1.26

0.22

4.6

7.7

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.21

0.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.21

0.0

1.1

—

(40768800) Prostate Pathology biopsy report

0.00

0.21

0.0

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

0.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.3

—

(4034850)

0.00

0.20

0.0

12.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.23

0.19

1.7

2.3

—

(3019150) Specific gravity of Urine by Refractometry

101

1.24

0.18

3.3

3.5

—

1.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

307

1.17

0.18

3.2

3.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

159

1.19

0.18

4.2

4.0

20.2

20.9

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

430

1.19

0.16

4.2

4.3

5.8

5.9

mmol/l

0.29

397

(40760892) CBC W Ordered Manual Differential panel - Blood

0.80

0.16

4.6

5.7

—

(40761511) CBC panel - Blood by Automated count

472

1.21

0.15

17.3

11.5

—

(3029937) Albumin [Presence] in Urine by Test strip

117

0.83

0.14

4.7

3.7

0.0

estimate

—

(40768804) Tissue Pathology biopsy report

166

0.87

0.11

2.2

2.0

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.18

0.10

1.4

2.9

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1.12

0.10

5.0

3.9

28.2

30.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

134

0.87

0.10

3.0

3.8

3.0

11.8

mg/mmol

—

(3022145) Colonoscopy Study observation

1.10

0.09

1.8

1.2

—

(3013512) EKG study

111

0.88

0.06

4.2

3.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

123

1.07

0.02

3.1

2.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

104

1.07

0.01

3.5

3.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

174

1.05

0.00

3.3

3.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

111

0.99

0.00

1.6

1.2

9.6

1.2

u/ml

—

(40768797) Stomach Pathology biopsy report

0.96

0.00

1.3

1.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.0

5.6

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

2.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.00

0.0

2.0

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.0

1.7

—

72.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.3

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.0

1.2

—

(3045424) Erythrocytes [Presence] in Urine

0.00

0.0

1.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.0

12.2

—

885.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.0

2.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

0.0

15.8

—

1572.7

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.2

—

12.9

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

0.93

0.00

1.7

412.4

472.6

pmol/l

—

(3011648) Oxygen content in Venous blood

0.00

0.0

1.8

—

12.8

—

(3004809) Band form neutrophils/100 leukocytes in Blood

0.00

0.0

2.0

—

3.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.8

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.2

—

129.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

0.0

1.0

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

0.00

0.0

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.4

—

0.0

—

(40768793) Breast Pathology biopsy report

0.00

0.0

1.4

—

(3024928) Oxygen saturation in Venous blood

0.00

0.0

1.6

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

9.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

0.0

1.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.0

1.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.3

—

(4306422)

0.00

0.0

1.2

—

(4268621)

0.00

0.0

1.9

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.0

3.1

—

17.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.0

2.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.6

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

0.00

0.0

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

2.2

—

(3042631) Mycobacterium sp identified in Specimen

0.00

0.0

1.8

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

4.0

—

92.6

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

0.0

2.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.5

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.0

—

107.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.0

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.0

4.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

-0.00

0.0

3.4

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_TRAUMAT_AMPUT_PART_HEAD – Traumatic amputation of part of head

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Traumatic amputation of part of head

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Traumatic amputation of part of head (ST19_TRAUMAT_AMPUT_PART_HEAD)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Relationships between endpoints